Bioethics paper: industry "buries" unfavorable studies

The always outstanding Carlat blog has a nice item this morning about the lengths pharmaceutical companies will go to in order to bury unfavorable results.

I used to enjoy playing "Devil's Advocate" with the drug reps, arguing points with them. I now realize that, as they say, the reps are always the last to know, and they just will say what they have been trained to say. Then they get laid off. It must be a tough job.

Somehow, researchers uncovered internal emails revealing that the pharma industry doesn't always get the results it's looking for when it studies its drugs. I tend to be pretty paranoid about these things anyway, so I really responded to this story!

http://carlatpsychiatry.blogspot.com/2010/02/lilly-execute-out-of-them.html